Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug ...

Investing.com -- HSBC has downgraded Chevron (NYSE: CVX) from Buy to Hold, citing reduced valuation upside and a cut to ...

Investing.com -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares tumbled 10.7% after the neuroscience-focused biopharmaceutical company reported first quarter earnings and announced a delay in ...

CompoSecure posted adjusted earnings per share of -$0.07 for the quarter, falling short of analyst estimates of $0.19. Revenue came in at $103.9 million, marginally above the consensus forecast of ...

For Q1 2025, Nayax posted adjusted earnings per share of $0.19, significantly beating the analyst consensus of $0.02. However, revenue came in at $81.1 million, missing the $85.08 million estimate.

SLINGERLANDS, N.Y. - Plug Power Inc. (NASDAQ:PLUG) reported first-quarter 2025 results that fell short of analyst expectations, sending shares down 2.6% in premarket trading Tuesday. The hydrogen ...

Investing.com -- Shares of Regenxbio Inc . (NASDAQ: RGNX) climbed 7.2% in premarket trading after the company announced the U.S. Food and Drug Administration (FDA) has accepted for priority review its ...

Despite the unfavorable trial results, iTeos Therapeutics has initiated a strategic review to maximize shareholder value. The company’s CEO, Michel Detheux, Ph.D., expressed disappointment over the ...